Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

SEPTEMBER 16, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. Voting agreements in public M&A transactions.

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

JANUARY 25, 2023

billion, a 36% decrease from 2021’s record high of $1.1 As was the case in 2021, software deals remained the strongest performer within the tech sector, representing approximately 90% of tech M&A deals. Deal volumes dropped from $531.13 billion [1] during the first half of 2022 to $189.17 trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

MergersCorp M&A International

MAY 27, 2025

Special Purpose Acquisition Companies (SPACs), once hailed as the “blank check” path to public markets, have experienced a rollercoaster ride over the past few years. After a boom in 2020 and 2021 that saw record-breaking volumes, the market cooled considerably in 2022 and 2023. What is a SPAC?

IPO 52

IPO Mergers and Acquisitions Investors Capital 52